CONNECT-FX Trial Completes Screening for Young Fragile X Patients to Test Cannabidiol Gel Zygel
A Phase 2/3 trial testing the cannabidiol gel Zygel as a treatment for behavioral symptoms in children and teenagers with fragile X syndrome has completed screening for eligible participants. As a result, Zynerba informed clinical sites that screening has closed. The…